Previous 10 | Next 10 |
2024-01-18 14:41:08 ET More on Eli Lilly, Novo Nordisk Taking Novo Nordisk To The Next Level Novo Nordisk: Enjoying The Tailwinds Of A Growing Market Eli Lilly: The Buzz Is Not Over Eli Lilly’s Jaypirca to lead BTK inhibitor market for leukemia ...
2024-01-18 13:25:54 ET Eli Lilly’s ( NYSE: LLY ) new cancer therapy, Jaypirca (pirtobrutinib), is expected to dominate the market for BTK inhibitors for chronic lymphocytic leukemia (CLL) in seven major markets, data and analytics firm GlobalData said Friday. BTK in...
2024-01-18 09:41:40 ET More on Coca-Cola Coca-Cola: Shares Fairly Priced, Strong Yield, Mixed Chart Ahead Of Q4 Earnings Coca-Cola May Suffer A Seismic Bearish Shift On Pharma's New Wonder Drugs Coca-Cola: Why A Bullish Thesis Isn't Hard To Understand Consume...
2024-01-18 01:03:18 ET Summary I make trades at the start of the new tax year to lock in gains and strengthen my portfolio. I focus on dividend growth stocks and have compiled a list of 25 stocks that I expect to provide double-digit dividend raises in 2024. I emphasize the im...
2024-01-17 17:32:22 ET Summary Alector, Inc. expects results from its phase 2 INVOKE-2 study, using AL002 for the treatment of patients with Alzheimer's disease, in Q4 of 2024. IND clearance received to begin a phase 2 study using AL101 for the treatment of patients with Alzheimer...
2024-01-16 14:10:03 ET Summary Demand for weight loss drugs and related stocks is high, with companies like Novo Nordisk and Eli Lilly experiencing significant returns. Omega Therapeutics may be a speculative investment opportunity in the weight loss drug market as it recently ent...
2024-01-16 10:50:09 ET Summary Investors are monitoring the S&P 500 stocks as the index starts the year with a pullback and uncertainty over interest rate cuts. Top-performing stocks include Juniper, Nvidia, Eli Lilly, Viatris, and Organon, while solar energy stocks and Boeing...
Shares of Eli Lilly and Company (NYSE: LLY) traded at a new 52-week high today and are currently trading at $565.71. So far today, approximately 2.29M shares have been exchanged, as compared to an average 30-day volume of 3.29M shares. Eli Lilly and Company discovers, develops, and markets hu...
2024-01-15 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-15 09:00:00 ET Summary Novo Nordisk stock remains a great buy at every dips, thanks to its expanding 2030 TAM to $150B, highly profitable growth trend, and improving balance sheet. Readers must also note that its growing oral/injectable diabetes/obesity pipelines, with its...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 07:07:00 ET If your portfolio doesn't have exposure to the biopharma businesses pursuing the development of weight loss medicines, it might be time to consider changing that situation. With an influx of new drugs for sale, and many competitors looking to secure their share of the...
2024-07-30 05:48:00 ET Going into 2024, DexCom 's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from individuals with diabetes. However, last week was the worst for De...
2024-07-29 15:13:21 ET Eli Lilly & Co (NYSE: LLY) has recently experienced a dramatic $123 billion decline in market value. This significant drop follows positive developments from competitors, notably Viking Therapeutics Inc and Roche Holding AG, who made announcements regarding th...